Understanding the ethical and regulatory challenges in Alzheimer’s disease research
Regulation & Ethics Core
['FUNDING_OTHER'] · BROWN UNIVERSITY · NIH-10673663
This study is looking at how to make research on Alzheimer’s and related dementias better and safer for patients, so we can find more effective treatments while making sure everyone’s rights are respected.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BROWN UNIVERSITY (nih funded) |
| Locations | 1 site (PROVIDENCE, UNITED STATES) |
| Trial ID | NIH-10673663 on ClinicalTrials.gov |
What this research studies
This research focuses on addressing the ethical and regulatory challenges associated with conducting embedded pragmatic clinical trials (ePCTs) for patients with Alzheimer’s disease and related dementias. It aims to improve the quality of care for individuals suffering from dementia by ensuring that their rights and interests are protected while facilitating research that can lead to better interventions. The project involves a multi-disciplinary team that will work to balance the needs of patients, caregivers, and healthcare systems, ultimately aiming to enhance the evidence base for effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with Alzheimer’s disease or related dementias.
Not a fit: Patients who do not have Alzheimer’s disease or related dementias may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved interventions and support services for patients with Alzheimer’s disease and their caregivers.
How similar studies have performed: Other research has shown success in addressing ethical and regulatory challenges in clinical trials for vulnerable populations, suggesting that this approach could be effective.
Where this research is happening
PROVIDENCE, UNITED STATES
- BROWN UNIVERSITY — PROVIDENCE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KARLAWISH, JASON H — BROWN UNIVERSITY
- Study coordinator: KARLAWISH, JASON H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome